25 May 2013
Keywords: lilly, launches, diabetes, drug, byetta, uk, usa-based
Article | 14 May 2007
USA-based drug major Eli Lilly says that the type 2 diabetes treatment Byetta (exenatide), co-developed with fellow US firm Amylin, is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 May 2007
24 May 2013
© 2013 thepharmaletter.com